CTX110 Trademark

Trademark Overview

On Monday, February 11, 2019, a trademark application was filed for CTX110 with the United States Patent and Trademark Office. The USPTO has given the CTX110 trademark a serial number of 88296694. The federal status of this trademark filing is REGISTERED as of Tuesday, June 14, 2022. This trademark is owned by CRISPR Therapeutics AG. The CTX110 trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer

Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
ctx110

General Information

Serial Number88296694
Word MarkCTX110
Filing DateMonday, February 11, 2019
Status700 - REGISTERED
Status DateTuesday, June 14, 2022
Registration Number6760727
Registration DateTuesday, June 14, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 17, 2019

Trademark Statements

Goods and ServicesCells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer
Goods and ServicesGene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 5, 2019
Primary Code005
First Use Anywhere DateMonday, July 22, 2019
First Use In Commerce DateMonday, July 22, 2019
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 2, 2019
Primary Code042
First Use Anywhere DateMonday, July 22, 2019
First Use In Commerce DateMonday, July 22, 2019

Trademark Owner History

Party NameCRISPR Therapeutics AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressZUG V8 6300
CH
Party NameCRISPR Therapeutics AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressZUG V8 6300
CH
Party NameCRISPR Therapeutics AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4051
CH

Trademark Events

Event DateEvent Description
Tuesday, June 14, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 14, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, May 10, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, May 9, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 27, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 12, 2022USE AMENDMENT FILED
Thursday, January 27, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 12, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, November 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 12, 2021SOU EXTENSION 4 GRANTED
Friday, November 12, 2021SOU EXTENSION 4 FILED
Friday, November 12, 2021TEAS EXTENSION RECEIVED
Friday, April 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 14, 2021SOU EXTENSION 3 GRANTED
Wednesday, April 14, 2021SOU EXTENSION 3 FILED
Wednesday, April 14, 2021TEAS EXTENSION RECEIVED
Wednesday, April 7, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 7, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 11, 2020SOU EXTENSION 2 GRANTED
Wednesday, November 11, 2020SOU EXTENSION 2 FILED
Wednesday, November 11, 2020TEAS EXTENSION RECEIVED
Wednesday, August 5, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 5, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, August 5, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 5, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 11, 2020SOU EXTENSION 1 GRANTED
Monday, May 11, 2020SOU EXTENSION 1 FILED
Monday, May 11, 2020TEAS EXTENSION RECEIVED
Tuesday, November 12, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 17, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 28, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 13, 2019ASSIGNED TO LIE
Tuesday, August 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 2, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 1, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 1, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 26, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 26, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 24, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 24, 2019NON-FINAL ACTION E-MAILED
Wednesday, April 24, 2019NON-FINAL ACTION WRITTEN
Friday, April 19, 2019ASSIGNED TO EXAMINER
Tuesday, March 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

gene treatment namely research editing pharmaceutical cancer medical development pharmaceuticals